Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

A protein S-targeting monoclonal antibody, VGA039, improves both primary and secondary hemostatic activity of von Willebrand disease patient blood in an ex vivo vascularized hemostasis-on-a-chip

Yumiko Sakurai, Megan Brown, Yongzhi Qiu, Elaissa Hardy, Tony Byun, Sandip Panicker, Wilbur Lam

Blood (2025) 146 (Supplement 1): 3051.

https://doi.org/10.1182/blood-2025-3051

Published: 2025

Journal Articles

Rates of inhibitor development and immune tolerance in children with severe Hemophilia A on emicizumab prophylaxis

Anna Schwartz, Bhavya Doshi, Karen Zimowski, Megan Brown, Kelly Tickle, Shannon Meeks, Michael White

Blood (2025) 146 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2025-4851

Published: 2025

Journal Articles

Emodin and DHA potently increase arsenic trioxide interferon-α–induced cell death of HTLV-I–transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1

Megan Brown, Marcia Bellon, Christophe Nicot

Blood (2006) 109 (4): 1653–1659.

https://doi.org/10.1182/blood-2006-04-015537

Published: 2006

Journal Articles

Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I–transformed cells

Uma Sinha-Datta, Izumi Horikawa, Eriko Michishita, Abhik Datta, Janitzia C. Sigler-Nicot, Megan Brown, Mirdad Kazanji, J. Carl Barrett, Christophe Nicot

Blood (2004) 104 (8): 2523–2531.

https://doi.org/10.1182/blood-2003-12-4251

Published: 2004

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A protein S-targeting monoclonal antibody, VGA039, improves both primary and secondary hemostatic activity of von Willebrand disease patient blood in an ex vivo vascularized hemostasis-on-a-chip

Rates of inhibitor development and immune tolerance in children with severe Hemophilia A on emicizumab prophylaxis

Emodin and DHA potently increase arsenic trioxide interferon-α–induced cell death of HTLV-I–transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1

Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I–transformed cells

Email alerts

ASH Publications

American Society of Hematology

Update search

A protein S-targeting monoclonal antibody, VGA039, improves both primary and secondary hemostatic activity of von Willebrand disease patient blood in an ex vivo vascularized hemostasis-on-a-chip

Rates of inhibitor development and immune tolerance in children with severe Hemophilia A on emicizumab prophylaxis

Emodin and DHA potently increase arsenic trioxide interferon-α–induced cell death of HTLV-I–transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1

Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I–transformed cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only